P David Southwell

Affiliations

  • Chief Executive Officer at Tscan Therapeutics Inc. (TCRX), 2022-07-27
  • at Rocket Pharmaceuticals Inc. (RCKT), 2022-06-16
  • Director at Ptc Therapeutics Inc. (PTCT), 2022-01-11
  • Director at Spero Therapeutics Inc. (SPRO), 2018-06-07
  • Chief Financial Officer at Human Genome Sciences Inc (HGSI), 2012-08-01
  • Director at Thl Credit Inc. (TCRD), 2010-12-07
  • Director at Biosphere Medical Inc (BSMD), 2010-09-10
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TCRX $3.55 10,000 Officer, Director 171,569 2022-05-18 Filing
TCRX $3.62 15,000 Officer, Director 161,569 2022-05-18 Filing
TCRX $8.73 11,000 Officer, Director 97,899 2021-09-08 Filing
ITEK $1.75 60,000 Officer, Director 62,765 2017-01-06 Filing
TCRD $13.00 10,200 Director 38,500 2010-12-06 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PTCT $52.18 500 Director 1,650 2020-10-16 Filing
PTCT $51.52 11,500 Director 2,150 2020-10-16 Filing
PTCT $52.18 700 Director 1,650 2020-10-16 Filing
PTCT $51.50 14,300 Director 2,350 2020-10-16 Filing
RCKT $15.19 38,768 95,160 2018-12-13 Filing